Drugs

Getting geroprotective drugs to market for specific disease applications is the first step in eventually making them available for healthier aging.

Oregon’s grand experiment in training psychedelic facilitators is facing a tangle of ambiguity and red tape.

How a daring team of parents and doctors forged a new path for medicine.

Fauna Bio mines squirrel genomes for clues to developing new drugs for humans.

These innovators are using their own bodies to build evidence for their hypotheses.

What to expect in genetic engineering, neuroscience, psychedelics, longevity research, digital health, food, human performance, wellbeing, and of course, ChatGPT.

AI can help overcome both scientific and financial hurdles to tackle this serious threat to global health.

Sarcopenia, a muscle wasting disease, could shorten your life and is alarmingly prevalent. Why are so many people unaware it exists?

Some studies show it’s better than SSRIs—but there’s no incentive to invest in clinical trials.

How drugs that hit targets for depression and kidney disease could help people suffering physical pain.